141 related articles for article (PubMed ID: 12995624)
1. [Therapeutic use of crataegus in cardiovascular diseases].
HERFORT H; LIERTZER V
Wien Med Wochenschr; 1952 Jul; 102(29/30):580-2. PubMed ID: 12995624
[No Abstract] [Full Text] [Related]
2. [Therapeutic use of crataegus, a result of modern botanic pharmacology].
MEYER E
Munch Med Wochenschr; 1952 Jun; 94(24):1225-8. PubMed ID: 12982796
[No Abstract] [Full Text] [Related]
3. [GLYCOSIDE THERAPY WITH OR WITHOUT CRATAEGUS?].
MUCK R
Hippokrates; 1963 Aug; 34():673-5. PubMed ID: 14047202
[No Abstract] [Full Text] [Related]
4. [Indications for Crataegus therapy].
STORCH H
Med Klin; 1954 Aug; 49(34):1331-4. PubMed ID: 13203011
[No Abstract] [Full Text] [Related]
5. [Crataegus in therapy of attrition diseases of the circulatory system].
STORCH H
Z Gesamte Inn Med; 1957 May; 12(9):400-5. PubMed ID: 13456746
[No Abstract] [Full Text] [Related]
6. [Problems of cardiac glycoside therapy].
SEMMLER F
Med Klin; 1963 Apr; 58():553-60. PubMed ID: 13987909
[No Abstract] [Full Text] [Related]
7. [Management of chronic cardiac insufficiency with crataegutt and stenocrat].
FISCHER AR
Munch Med Wochenschr; 1956 Apr; 98(17):605-6. PubMed ID: 13334448
[No Abstract] [Full Text] [Related]
8. [Practical experiences with miroton in therapy of cardiovascular diseases].
STOHR W
Hippokrates; 1952 Dec; 23(23):676-8. PubMed ID: 13034159
[No Abstract] [Full Text] [Related]
9. [Crataegutt, the cardiovascular agent of our times].
FRUEHAUF H
Hippokrates; 1961 Jul; 32():527-30. PubMed ID: 13702299
[No Abstract] [Full Text] [Related]
10. [The effect of a Crataegus effective substance on the heart and the blood circulation (heptaoxyflavanglykosid)].
HILLE H; SCHAEFER H; TESKE HJ; ZIPF KE
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 227(3):281-92. PubMed ID: 13309425
[No Abstract] [Full Text] [Related]
11. [The effect of the aqueous solution of an active principle, heptahydroxyflavanglycoside, from Crataegus on the heart and circulation in dogs].
ENGELKING R; WILLIG F
Arzneimittelforschung; 1958 Jan; 8(1):39-42. PubMed ID: 13510154
[No Abstract] [Full Text] [Related]
12. [On pharmacology of corulin].
ANGARSKAIA MA; SOKOLOVA VE; KHADZHAI IaI
Farmakol Toksikol; 1961; 24():163-8. PubMed ID: 13683527
[No Abstract] [Full Text] [Related]
13. [Results in studies on Crataegus. II. Experimental findings with total extracts and isolated purified substances of Crataegus].
BOHM K
Arzneimittelforschung; 1956 Jan; 6(1):38-41. PubMed ID: 13293097
[No Abstract] [Full Text] [Related]
14. [Treatment of cardiovascular disorders in aged with Crataegus & Convallaria majalis].
SIEBENHAAR C
Med Klin; 1956 Oct; 51(43):1827-33. PubMed ID: 13386810
[No Abstract] [Full Text] [Related]
15. Clinical experience in therapy of heart diseases with Crataegus.
STIRN A
Medizinische; 1954 Dec; 49():1651-3. PubMed ID: 13235147
[No Abstract] [Full Text] [Related]
16. [On heart therapy with reserpine and Crataegus].
FESER A
Med Klin; 1960 Jul; 55():1323-4. PubMed ID: 13822553
[No Abstract] [Full Text] [Related]
17. [Critical considerations on the use of an injectable crataegus preparation].
BECKER A
Hippokrates; 1956 May; 27(10):322-7. PubMed ID: 13331415
[No Abstract] [Full Text] [Related]
18. [On the practical significance of the combination of Crataegus with sedative acting substances in the treatment of heart diseases].
ENGELHARDT A; TREZZINI F
Med Monatsschr; 1960 Jan; 14():26-9. PubMed ID: 13820331
[No Abstract] [Full Text] [Related]
19. [Digitalis-lanata-Crataegus in therapy of heart diseases].
LEUTIGER H
Medizinische; 1957 Jun; (26):984-7. PubMed ID: 13451036
[No Abstract] [Full Text] [Related]
20. [Clinical experience with the purified glycoside convallatoxin].
WEISE H; ESSER H
Med Klin; 1956 Mar; 51(11):432-3. PubMed ID: 13308774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
